Home » BRADLEY SIGNS COPROMOTION AGREEMENT WITH MISSION
BRADLEY SIGNS COPROMOTION AGREEMENT WITH MISSION
Bradley Pharmaceuticals today announced that an agreement has been signed with Mission Pharmacal, a privately held pharmaceutical company specializing in women's health, to co-promote AnaMantle HC Cream (lidocaine HCl 3 percent/hydrocortisone acetate 0.5 percent), a clean, neat and disposable therapy used for the anti-inflammatory and anesthetic relief of discomfort due to hemorrhoids, to OB/GYN physicians.
PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=251082&categoryid=10)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May